CClinicalTrials.gg
Status unknownNCT02784041Updated Apr 6, 2017

Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty

An interventional study of single adductor-canal-block and periarticular infiltration in Osteoarthritis,Knee, sponsored by Peking Union Medical College Hospital. Status unknown at 1 site in China. Open to participants aged 45 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-06.

Sponsored by Peking Union Medical College Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2016), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
45 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to compare the effect of single adductor-canal-block versus single femoral nerve block on the recovery after total knee arthroplasty.

Read the detailed description

The aim of this study is to assess the effect of different analgesic effects on the outcome of patients undergoing total knee arthroplasty. Patients who will have primary unilateral total knee replacement between September 2016 to June 2018 at Peking Union Medical College Hospital and meet the inclusion criteria will be included. They are randomized into two groups. The total knee arthroplasty is performed by one surgeon and adductor-canal block is performed by one anesthesiologist who is not responsible for follow-up. Patients on both groups will have intravenous patient control analgesia with 1 mg morphine/bolus. One residency is responsible for the follow-up.

02

Conditions studied

  • Osteoarthritis,Knee

Keywords

  • knee arthroplasty
  • adductor canal block
  • periarticular infiltration
03

In context

Osteoarthritis, Knee

3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.

This study's planned enrollment of 200 is above the median of 70 across 2,731 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Peking Union Medical College Hospital is the lead sponsor of 1,115 studies on the registry; 463 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • osteoarthritis
  • unilateral total knee arthroplasty
  • ASA grade I - II
  • normal cognitive function.

Exclusion criteria

Exclusion Criteria:

  • patients refuse
  • BMI > 35
  • diagnosis other than osteoarthritis
  • allergy to the drugs used or contraindication to the intervention
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    single adductor-canal-block

    Patients in this group will receive ultrasound guided single adductor-canal- block with 0.35% ropivacaine 25ml.

    Drug: single adductor-canal-block

  • Experimental
    periarticular infiltration

    patients in this group will receive periarticular infiltration of local anesthetic.

    Drug: periarticular infiltration

Interventions

  • Drugsingle adductor-canal-block

    Single adductor-canal-block is performed before the surgery. A 12Hz linear ultrasound transducer is placed on the medial part of the thigh with the leg slightly externally rotated. The femoral artery was identified in short axis in the adductor canal, underneath the sartorius muscle. After skin disinfection , an 18-gauge needle (B.Braun Medical, Melsungen, Germany) is inserted in-plane from the lateral side of the transducer. The needle tip was placed underneath the sartorius muscle, just lateral to the artery and saphenous nerve, using 2-3 ml of saline to ensure correct placement. 25 ml of 0.35% ropivacaine is slowly injected with repeated aspiration.

  • Drugperiarticular infiltration

    The periarticular infiltration of multimodal agents will involve the preparation of a mixture of 100 ml solution. The mixture contains 30ml (300mg) ropivacaine, 0.5ml (5 mg) morphine, 2 ml (50 mg) flurbiprofen and 0.5 ml of 1:1000 epinephrine, and then is diluted with 0.9% normal saline to a total volume of 100ml. 50 ml of mixture will be injected into the anterior, medial and lateral soft tissues after the implantation of the joint prostheses. The remaining 50 ml of mixture will be injected into intraarticular space after the closure of articular capsule.

06

What researchers measure

Primary outcomes

  1. the time required for functional recovery

    Patients are evaluated postoperatively to determine whether the patients have meet the criteria of functional recovery.The criteria of functional recovery are as followings: walking distance more than 70m with crutch, getting up or standing up independently and visual analog score less than 5 both in rest and after movement. Before discharge, patients are assessed every morning. After discharge, patients are followed up by phone every two days.

    Time frame: from the date of the surgery to the time when the patients meet the criteria of functional recovery. The earliest day on which the patient achieves the criteria of functional recovery will be recorded and the average time is 7 days after surgery.

Secondary outcomes

  1. postoperative WOMAC scales

    We compare the WOMAC scales of two groups before, three months, six months, and one year after the surgery.

    Time frame: pre-operative, three months,six months and one year afer the surgery

  2. Postoperative complications

    Any complication, including nause and vomiting, deep vein thrombosis, pulmonary embolism, pulmonary infection, urinary tract infection,cardiovascular event and falls are recorded during inhospital stay.

    Time frame: daily after the surgery until discharge from hospital, expected average up to 5 days after the surgery

  3. postoperative VAS scale

    Pain at rest and while moving are evaluated by a visual analog scale preoperative, 6h, 24h, 48h, 1month, 3 months and 1 year after the surgery.

    Time frame: pre-operative, 6h postoperative, 24h postoperative, 48h postoperative, one month postoperative, three-month postoperative, one year postoperative

  4. postoperative morphine consumption

    Consumptions of morphine are recorded at 6h, 24h, 48h after the surgery.

    Time frame: 6h, 24h, 48h after the surgery

  5. postoperative SF-36 score

    We compare the SF-36 score of two groups before, three months,six months and one year after the surgery.

    Time frame: pre-operative, three months,six months and one year afer the surgery

Other outcomes

  1. patients' satisfaction

    The degree of satisfaction with surgery outcomes is assessed on a scale from fully satisfied to dissatisfied .

    Time frame: before discharge, usually 3-4 days after the surgery and one year after the surgery

07

Study locations

1 site
  • Peking Union Medical College Hospital
    Beijing, 100730, China
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02784041
Lead sponsor
Peking Union Medical College Hospital
Responsible party
Sponsor
First posted
May 26, 2016
Start date
Sep 2016
Primary completion
Dec 2017 (estimated)
Completion
Dec 2018 (estimated)
Last update
Apr 6, 2017

Study contacts

Yuguang Huang, Dr
study chair · Peking Union Medical College Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion